SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
| Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
| Duquesne Family Office | 100,000 | $150 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
| Ergoteles LLC | 15,521 | $23,282 | 0.00% |
| UBS Group AG | 3,440 | $5,160 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |